Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases

Neonatal tumors are rare with no standard treatment approaches to these diseases, and the patients experience poor outcomes. Our aim was to determine the distribution of cancers affecting neonates and compare survival between these cancers and older children. We analyzed SEER data (1973–2007) from p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer medicine (Malden, MA) MA), 2017-07, Vol.6 (7), p.1817-1826
Hauptverfasser: Alfaar, Ahmad S., Hassan, Waleed M., Bakry, Mohamed Sabry, Qaddoumi, Ibrahim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1826
container_issue 7
container_start_page 1817
container_title Cancer medicine (Malden, MA)
container_volume 6
creator Alfaar, Ahmad S.
Hassan, Waleed M.
Bakry, Mohamed Sabry
Qaddoumi, Ibrahim
description Neonatal tumors are rare with no standard treatment approaches to these diseases, and the patients experience poor outcomes. Our aim was to determine the distribution of cancers affecting neonates and compare survival between these cancers and older children. We analyzed SEER data (1973–2007) from patients who were younger than 2 years at diagnosis of malignancy. Special permission was granted to access the detailed (i.e., age in months) data of those patients. The Chi‐square Log‐rank test was used to compare survival between neonates (aged 1 month to
doi_str_mv 10.1002/cam4.1122
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5504346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1912617951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4432-58d4369684c1ff46db788d476dd9dedf500dffabd0b683a100a75388af80f09e3</originalsourceid><addsrcrecordid>eNp1kUtLxDAUhYMoKurCPyABN7qYmaR5tQiCDOMDfICvbUibxKm0iSat4r83dVRUMJtcTj4O9-QAsI3RGCOUTSrV0jHGWbYE1jNE2UhwQpd_zGtgK8ZHlI5AGRd4FaxlOSeFIGwd3F8a71RnInytuzmslKtMgMrpNPYxyd5CbVQ3P4CNidG7CG3wLeSYJWIAage7uYE3s9k11KpT5aBughWrmmi2Pu8NcHc8u52ejs6vTs6mR-ejilKSjViuKeEFz2mFraVclyJPkuBaF9poyxDS1qpSo5LnRKW8SjCS58rmyKLCkA1wuPB96svW6Mq4LqhGPoW6VeFNelXL3y-unssH_yIZQ5RQngz2Pg2Cf-5N7GRbx8o0jXLG91HiAmcci4LhhO7-QR99H1yKN1Ai_UiKlKj9BVUFH2Mw9nsZjORQmBwKk0Nhid35uf03-VVPAiYL4LVuzNv_TnJ6dEE_LN8BB6Cd6Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1917615432</pqid></control><display><type>article</type><title>Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases</title><source>Access via Wiley Online Library</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Alfaar, Ahmad S. ; Hassan, Waleed M. ; Bakry, Mohamed Sabry ; Qaddoumi, Ibrahim</creator><creatorcontrib>Alfaar, Ahmad S. ; Hassan, Waleed M. ; Bakry, Mohamed Sabry ; Qaddoumi, Ibrahim</creatorcontrib><description>Neonatal tumors are rare with no standard treatment approaches to these diseases, and the patients experience poor outcomes. Our aim was to determine the distribution of cancers affecting neonates and compare survival between these cancers and older children. We analyzed SEER data (1973–2007) from patients who were younger than 2 years at diagnosis of malignancy. Special permission was granted to access the detailed (i.e., age in months) data of those patients. The Chi‐square Log‐rank test was used to compare survival between neonates (aged &lt;1 month) and older children (&gt;1 month to &lt;2 years). We identified 615 neonatal cancers (454 solid tumors, 93 leukemia/lymphoma, and 68 CNS neoplasms). Neuroblastoma was the most common neonatal tumor followed by Germ cell tumors. The 5‐year overall survival (OS) for all neonates was 60.3% (95% CI, 56.2–64.4). Neonates with solid tumors had the highest 5‐year OS (71.2%; 95% CI, 66.9–75.5), followed by those with leukemia (39.1%; 95% CI, 28.3–49.9) or CNS tumors (15%; 95% CI, 5.4–24.6). Except for neuroblastoma, all neonatal tumors showed inferior outcomes compared to that in the older group. The proportion of neonates who died from causes other than cancer was significantly higher than that of the older children (37.9% vs. 16.4%; P &lt; 0.0005). In general, the outcome of neonatal cancers has not improved over the last 34 years. The distribution of neonatal cancer is different than other pediatric age groups. Although the progress in neonatal and cancer care over the last 30 years, only death from noncancer causes showed improvement. Studying neonatal tumors as part of national studies is essential to understand their etiology, determine the best treatment approaches, and improve survival and quality of life for those patients. Neonates with solid tumors had the highest 5‐year OS, followed by those with leukemia or CNS tumors. Except for neuroblastoma, all neonatal tumors showed inferior outcomes compared to that in the older group. The proportion of neonates who died from causes other than cancer was significantly higher than that of the older children but in general, the outcome of neonatal cancers has not improved over the last 34 years.</description><identifier>ISSN: 2045-7634</identifier><identifier>EISSN: 2045-7634</identifier><identifier>DOI: 10.1002/cam4.1122</identifier><identifier>PMID: 28639735</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Cancer ; Cancer Prevention ; Cause of Death ; Children ; Epidemiology ; Etiology ; Female ; Humans ; infancy ; Infant ; Infant, Newborn ; Infant, Newborn, Diseases - epidemiology ; Infant, Newborn, Diseases - mortality ; Leukemia ; Lymphoma ; Male ; Malignancy ; neonatal tumors ; Neonates ; Neoplasms - diagnosis ; Neoplasms - epidemiology ; Neoplasms - mortality ; Neoplasms - therapy ; Neuroblastoma ; Original Research ; Outcome Assessment, Health Care ; Patients ; Quality of life ; SEER ; SEER Program ; Solid tumors ; Tumors ; undertreatment ; United States - epidemiology</subject><ispartof>Cancer medicine (Malden, MA), 2017-07, Vol.6 (7), p.1817-1826</ispartof><rights>2017 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2017 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</rights><rights>2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4432-58d4369684c1ff46db788d476dd9dedf500dffabd0b683a100a75388af80f09e3</citedby><cites>FETCH-LOGICAL-c4432-58d4369684c1ff46db788d476dd9dedf500dffabd0b683a100a75388af80f09e3</cites><orcidid>0000-0002-0930-4583 ; 0000-0001-9750-9230</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504346/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504346/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,1419,11571,27933,27934,45583,45584,46061,46485,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28639735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alfaar, Ahmad S.</creatorcontrib><creatorcontrib>Hassan, Waleed M.</creatorcontrib><creatorcontrib>Bakry, Mohamed Sabry</creatorcontrib><creatorcontrib>Qaddoumi, Ibrahim</creatorcontrib><title>Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases</title><title>Cancer medicine (Malden, MA)</title><addtitle>Cancer Med</addtitle><description>Neonatal tumors are rare with no standard treatment approaches to these diseases, and the patients experience poor outcomes. Our aim was to determine the distribution of cancers affecting neonates and compare survival between these cancers and older children. We analyzed SEER data (1973–2007) from patients who were younger than 2 years at diagnosis of malignancy. Special permission was granted to access the detailed (i.e., age in months) data of those patients. The Chi‐square Log‐rank test was used to compare survival between neonates (aged &lt;1 month) and older children (&gt;1 month to &lt;2 years). We identified 615 neonatal cancers (454 solid tumors, 93 leukemia/lymphoma, and 68 CNS neoplasms). Neuroblastoma was the most common neonatal tumor followed by Germ cell tumors. The 5‐year overall survival (OS) for all neonates was 60.3% (95% CI, 56.2–64.4). Neonates with solid tumors had the highest 5‐year OS (71.2%; 95% CI, 66.9–75.5), followed by those with leukemia (39.1%; 95% CI, 28.3–49.9) or CNS tumors (15%; 95% CI, 5.4–24.6). Except for neuroblastoma, all neonatal tumors showed inferior outcomes compared to that in the older group. The proportion of neonates who died from causes other than cancer was significantly higher than that of the older children (37.9% vs. 16.4%; P &lt; 0.0005). In general, the outcome of neonatal cancers has not improved over the last 34 years. The distribution of neonatal cancer is different than other pediatric age groups. Although the progress in neonatal and cancer care over the last 30 years, only death from noncancer causes showed improvement. Studying neonatal tumors as part of national studies is essential to understand their etiology, determine the best treatment approaches, and improve survival and quality of life for those patients. Neonates with solid tumors had the highest 5‐year OS, followed by those with leukemia or CNS tumors. Except for neuroblastoma, all neonatal tumors showed inferior outcomes compared to that in the older group. The proportion of neonates who died from causes other than cancer was significantly higher than that of the older children but in general, the outcome of neonatal cancers has not improved over the last 34 years.</description><subject>Cancer</subject><subject>Cancer Prevention</subject><subject>Cause of Death</subject><subject>Children</subject><subject>Epidemiology</subject><subject>Etiology</subject><subject>Female</subject><subject>Humans</subject><subject>infancy</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Newborn, Diseases - epidemiology</subject><subject>Infant, Newborn, Diseases - mortality</subject><subject>Leukemia</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Malignancy</subject><subject>neonatal tumors</subject><subject>Neonates</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - mortality</subject><subject>Neoplasms - therapy</subject><subject>Neuroblastoma</subject><subject>Original Research</subject><subject>Outcome Assessment, Health Care</subject><subject>Patients</subject><subject>Quality of life</subject><subject>SEER</subject><subject>SEER Program</subject><subject>Solid tumors</subject><subject>Tumors</subject><subject>undertreatment</subject><subject>United States - epidemiology</subject><issn>2045-7634</issn><issn>2045-7634</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUtLxDAUhYMoKurCPyABN7qYmaR5tQiCDOMDfICvbUibxKm0iSat4r83dVRUMJtcTj4O9-QAsI3RGCOUTSrV0jHGWbYE1jNE2UhwQpd_zGtgK8ZHlI5AGRd4FaxlOSeFIGwd3F8a71RnInytuzmslKtMgMrpNPYxyd5CbVQ3P4CNidG7CG3wLeSYJWIAage7uYE3s9k11KpT5aBughWrmmi2Pu8NcHc8u52ejs6vTs6mR-ejilKSjViuKeEFz2mFraVclyJPkuBaF9poyxDS1qpSo5LnRKW8SjCS58rmyKLCkA1wuPB96svW6Mq4LqhGPoW6VeFNelXL3y-unssH_yIZQ5RQngz2Pg2Cf-5N7GRbx8o0jXLG91HiAmcci4LhhO7-QR99H1yKN1Ai_UiKlKj9BVUFH2Mw9nsZjORQmBwKk0Nhid35uf03-VVPAiYL4LVuzNv_TnJ6dEE_LN8BB6Cd6Q</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Alfaar, Ahmad S.</creator><creator>Hassan, Waleed M.</creator><creator>Bakry, Mohamed Sabry</creator><creator>Qaddoumi, Ibrahim</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0930-4583</orcidid><orcidid>https://orcid.org/0000-0001-9750-9230</orcidid></search><sort><creationdate>201707</creationdate><title>Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases</title><author>Alfaar, Ahmad S. ; Hassan, Waleed M. ; Bakry, Mohamed Sabry ; Qaddoumi, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4432-58d4369684c1ff46db788d476dd9dedf500dffabd0b683a100a75388af80f09e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cancer</topic><topic>Cancer Prevention</topic><topic>Cause of Death</topic><topic>Children</topic><topic>Epidemiology</topic><topic>Etiology</topic><topic>Female</topic><topic>Humans</topic><topic>infancy</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Newborn, Diseases - epidemiology</topic><topic>Infant, Newborn, Diseases - mortality</topic><topic>Leukemia</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Malignancy</topic><topic>neonatal tumors</topic><topic>Neonates</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - mortality</topic><topic>Neoplasms - therapy</topic><topic>Neuroblastoma</topic><topic>Original Research</topic><topic>Outcome Assessment, Health Care</topic><topic>Patients</topic><topic>Quality of life</topic><topic>SEER</topic><topic>SEER Program</topic><topic>Solid tumors</topic><topic>Tumors</topic><topic>undertreatment</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alfaar, Ahmad S.</creatorcontrib><creatorcontrib>Hassan, Waleed M.</creatorcontrib><creatorcontrib>Bakry, Mohamed Sabry</creatorcontrib><creatorcontrib>Qaddoumi, Ibrahim</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer medicine (Malden, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alfaar, Ahmad S.</au><au>Hassan, Waleed M.</au><au>Bakry, Mohamed Sabry</au><au>Qaddoumi, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases</atitle><jtitle>Cancer medicine (Malden, MA)</jtitle><addtitle>Cancer Med</addtitle><date>2017-07</date><risdate>2017</risdate><volume>6</volume><issue>7</issue><spage>1817</spage><epage>1826</epage><pages>1817-1826</pages><issn>2045-7634</issn><eissn>2045-7634</eissn><abstract>Neonatal tumors are rare with no standard treatment approaches to these diseases, and the patients experience poor outcomes. Our aim was to determine the distribution of cancers affecting neonates and compare survival between these cancers and older children. We analyzed SEER data (1973–2007) from patients who were younger than 2 years at diagnosis of malignancy. Special permission was granted to access the detailed (i.e., age in months) data of those patients. The Chi‐square Log‐rank test was used to compare survival between neonates (aged &lt;1 month) and older children (&gt;1 month to &lt;2 years). We identified 615 neonatal cancers (454 solid tumors, 93 leukemia/lymphoma, and 68 CNS neoplasms). Neuroblastoma was the most common neonatal tumor followed by Germ cell tumors. The 5‐year overall survival (OS) for all neonates was 60.3% (95% CI, 56.2–64.4). Neonates with solid tumors had the highest 5‐year OS (71.2%; 95% CI, 66.9–75.5), followed by those with leukemia (39.1%; 95% CI, 28.3–49.9) or CNS tumors (15%; 95% CI, 5.4–24.6). Except for neuroblastoma, all neonatal tumors showed inferior outcomes compared to that in the older group. The proportion of neonates who died from causes other than cancer was significantly higher than that of the older children (37.9% vs. 16.4%; P &lt; 0.0005). In general, the outcome of neonatal cancers has not improved over the last 34 years. The distribution of neonatal cancer is different than other pediatric age groups. Although the progress in neonatal and cancer care over the last 30 years, only death from noncancer causes showed improvement. Studying neonatal tumors as part of national studies is essential to understand their etiology, determine the best treatment approaches, and improve survival and quality of life for those patients. Neonates with solid tumors had the highest 5‐year OS, followed by those with leukemia or CNS tumors. Except for neuroblastoma, all neonatal tumors showed inferior outcomes compared to that in the older group. The proportion of neonates who died from causes other than cancer was significantly higher than that of the older children but in general, the outcome of neonatal cancers has not improved over the last 34 years.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>28639735</pmid><doi>10.1002/cam4.1122</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-0930-4583</orcidid><orcidid>https://orcid.org/0000-0001-9750-9230</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-7634
ispartof Cancer medicine (Malden, MA), 2017-07, Vol.6 (7), p.1817-1826
issn 2045-7634
2045-7634
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5504346
source Access via Wiley Online Library; MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Online Library (Open Access Collection); PubMed Central
subjects Cancer
Cancer Prevention
Cause of Death
Children
Epidemiology
Etiology
Female
Humans
infancy
Infant
Infant, Newborn
Infant, Newborn, Diseases - epidemiology
Infant, Newborn, Diseases - mortality
Leukemia
Lymphoma
Male
Malignancy
neonatal tumors
Neonates
Neoplasms - diagnosis
Neoplasms - epidemiology
Neoplasms - mortality
Neoplasms - therapy
Neuroblastoma
Original Research
Outcome Assessment, Health Care
Patients
Quality of life
SEER
SEER Program
Solid tumors
Tumors
undertreatment
United States - epidemiology
title Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T11%3A30%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonates%20with%20cancer%20and%20causes%20of%20death;%20lessons%20from%20615%20cases%20in%20the%20SEER%20databases&rft.jtitle=Cancer%20medicine%20(Malden,%20MA)&rft.au=Alfaar,%20Ahmad%20S.&rft.date=2017-07&rft.volume=6&rft.issue=7&rft.spage=1817&rft.epage=1826&rft.pages=1817-1826&rft.issn=2045-7634&rft.eissn=2045-7634&rft_id=info:doi/10.1002/cam4.1122&rft_dat=%3Cproquest_pubme%3E1912617951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1917615432&rft_id=info:pmid/28639735&rfr_iscdi=true